News

Molecure S.A. is a biotechnology company specializing in the development of innovative drugs for treating various incurable diseases. The company focuses on leveraging its expertise

Today, the U.S. Food and Drug Administration has approved Duvyzat, an oral medication, for treating Duchenne Muscular Dystrophy in patients aged six and above. Duvyzat is notable for being the first nonsteroidal drug

Cabaletta Bio, Inc. has recently gained Orphan Drug Designation from the U.S. Food and Drug Administration for its investigational therapy, CABA-201, aimed at treating systemic sclerosis

Puma Biotechnology, Inc., a biopharmaceutical company, has received approval from the U.S. Food and Drug Administration for its Investigational New Drug Application concerning alisertib. This allows Puma to progress with clinical trials

Takeda has recently announced that the U.S. Food and Drug Administration approved the supplemental New Drug Application for ICLUSIG®. This approval expands the usage of ICLUSIG to treat adult patients

Telix Pharmaceuticals Limited has revealed a new partnership for its QDOSE® dosimetry software platform with ABX-CRO Advanced Pharmaceutical Services Forschungsgesellschaft mbH

KeChow Pharma, a prominent pharmaceutical company specializing in developing and commercializing innovative small molecule therapeutics for cancer, has reached a significant achievement.

Optinose , a pharmaceutical company that focuses on treatments for ear, nose, and throat issues as well as allergies, has announced that the U.S. Food and Drug Administration has granted approval for XHANCE®

Sino Biological, Inc., a major biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext, has forged a notable partnership with Rapid Novor, Inc, headquartered in Toronto

ProteoNic Biosciences, a leader in vector technology and services for biologics production, has announced a partnership with Ginkgo Bioworks, known for its advancements in cell programming and biosecurity